NasdaqCM:ZURABiotechs
Does Zura Bio's (ZURA) Severance Plan Reflect Management's Priorities Amid Cash Burn Pressures?
On September 24, 2025, Zura Bio Limited adopted an Executive Severance Benefit Plan, outlining compensation for executives if terminated without cause or upon resignation for good reason, especially in the context of a change in control.
This move comes as the company, which reported having US$154 million in cash with a reported runway of 3.5 years as of June 2025, faces scrutiny over its increasing cash burn and potential funding needs.
We'll examine how concerns around Zura Bio's executive...